Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2006 Oct;132(10):665-71.
doi: 10.1007/s00432-006-0115-7. Epub 2006 Jul 5.

Impairment in functional status and survival in patients with acute myeloid leukaemia

Ulrich Wedding  1 , Bernd Röhrig, Almuth Klippstein, Hans-Joerg Fricke, Herbert G Sayer, Klaus Höffken
Affiliations
Comparative Study

Impairment in functional status and survival in patients with acute myeloid leukaemia

Ulrich Wedding et al. J Cancer Res Clin Oncol. 2006 Oct.

Abstract

Acute myeloid leukaemia (AML) is mainly affecting elderly patients. Elderly patients are increasingly affected by impairment of functional status (FS). FS is of prognostic relevance for survival in different tumours. Data for patients with AML are rare. Within a prospective trial we recruited patients with newly diagnosed AML and measured FS by two different methods: Karnofsky performance status (KPS) and instrumental activities of daily living (IADL). Sixty-three patients aged 19-85 years (median 61.1) were included. Twenty-three had prior myelodisplastic syndrome (MDS), 7 favourable, 17 unfavourable karyotype. Fifty received induction chemotherapy, 13 palliative chemotherapy. Median survival was 15.2 months (95% CI, 10.8-22.3) in all patients. Age, cytogenetic risk group, and impaired KPS and IADL significantly influenced median survival in univariate analysis. Impairment of IADL was the single most predictive variable. In multivariate analysis, impairment of IADL Score (HR:4.3, 95% CI 1.7-10.5, P = 0.001) and of KPS (HR:4.8, 95% CI 1.9-12.3, P = 0.001), and unfavourable cytogenetic risk group (HR:6.0, 95% CI 2.5-14.3, P < 0.001) significantly predicted median survival. In patients with AML, FS and not age is a major predictor of survival. The influence of FS is independent from cytogenetic risk group. IADL measurement adds information to KPS. The results have to be confirmed in a large sample of patients.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Median survival curves (Kaplan–Meier) according (a) to cytogenetics (b) to Karnofsky performance status and (c) to instrumental activities of daily living
See this image and copyright information in PMC

References

    1. Afifi AA (1984) Computer-aided multivariate analysis. Chapman & Hall/ CRC, New York
    1. Altman DG (1991) Practical statistics for medical research. Chapman & Hall, London
    1. Belsley DA, Kuh E, Welsch RE (1984) Regression diagnostics: identifying influential data and sources of collinearity. Wiley, New York
    1. Bennett JM et al (1976) Proposals for the classification of the acute leukaemias. French–American–British (FAB) cooperative group. Br J Haematol33(4):451–458 - PubMed
    1. Byrd JC et al (2002) Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461). Blood 100(13):4325–4336 - PubMed

Publication types